title: Glucocorticoid enhances Na(+)/K(+) ATPase mRNA expression in rat olfactory mucosa during regeneration: a possible mechanism for recovery from olfactory disturbance.
abstract: Systemic or topical application of glucocorticoid is the treatment of choice for olfactory disturbance. Recently, Na(+)/K(+) ATPase and glucocorticoid receptor immunoreactivity in the olfactory mucosa was reported. To elucidate a glucocorticoid action on Na(+)/K(+) ATPase production, an animal model was produced by an intra-nasal application of 5% ZnSO(4) solution to Wistar rats. Dexamethasone was injected i.p. (0.01 mg/100 g) for 14 days after the insult. Histologically, the regeneration process was completed on day 14 in both dexamethasone- and saline-injected control rats. We used a quantitative polymerase chain reaction (PCR) method to evaluate mRNA production of Na(+)/K(+) ATPase and glucocorticoid receptor. In dexamethasone-injected rats, up-regulation of glucocorticoid receptor mRNA (95% more than control rats, P = 0.00068, unpaired t-test) and of Na(+)/K(+) ATPase mRNA expression (76% more than control rats, P = 0.0042) was observed on day 14. The increased Na(+)/K(+) ATPase expression in the regenerated olfactory mucosa is thought to be beneficial for an active uptake of K(+), which is released during excitation, around olfactory neurons and for the transepithelial absorption of Na(+) from olfactory mucus. Dexamethasone may thus contribute to the recovery of function after the morphological regeneration in part, at least, through its receptor by regulation of the ionic concentration in the olfactory mucosal microenvironment.
authors.affiliation: Department of Otorhinolaryngology, Kanazawa University School of Medicine, Kanazawa, Ishikawa, Japan. nishimut@orl.m.kanazawa-u.ac.jp
authors.forename: Toshiro
authors.initials: T
authors.lastname: Nishimura
authors.forename: Shigekazu
authors.initials: S
authors.lastname: Teranishi
authors.forename: Atsuhiro
authors.initials: A
authors.lastname: Kawashima
authors.forename: Tadashi
authors.initials: T
authors.lastname: Ishimaru
authors.forename: Takaki
authors.initials: T
authors.lastname: Miwa
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Furukawa
mesh_terms: D000818:Animals; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology; D005938:Glucocorticoids / Q000008:administration & dosage / Q000494:pharmacology*; D007150:Immunohistochemistry; D008297:Male; D009831:Olfactory Mucosa / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D011965:Receptors, Glucocorticoid / Q000096:biosynthesis / Q000187:drug effects / Q000235:genetics; D012038:Regeneration / Q000187:drug effects*; D000254:Sodium-Potassium-Exchanging ATPase / Q000096:biosynthesis / Q000187:drug effects* / Q000235:genetics; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D005938:Glucocorticoids; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D003907:Dexamethasone; D000254:Sodium-Potassium-Exchanging ATPase